A trial recruiting in the United States says it pays volunteers: Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination.
First on record. The first time trial NCT07910266 appears on this study's record, which starts Oct 31, 2026.Coinjure recorded this at 19:20 UTC on Nov 2Stamped 2026-11-02 19:20 UTC. Never edited, never back-dated.
Details, as recorded
As recorded: Paid trial recruiting in United States: Impact of Egg-Based and Cell-Based Vaccine Platforms on Immune Responses to Repeated Influenza Vaccination (NCT07910266)
"Cell-based then 2nd shot Egg-based Participants will receive a $20 Amazon e-gift card for each blood specimen collection completed." (registry text). Condition: Immunology. Trial phase 4. Accepts healthy volunteers. First posted 2 Nov 2026. https://clinicaltrials.gov/study/NCT07910266. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine), trials with status Recruiting whose summary, description or eligibility text says participants are paid or compensated. A trial that pays but does not say so in the registry is not counted. Not medical advice. Read the trial's own page and talk to a doctor before you sign up.
From Paid clinical trials recruiting now, run by Coinjure. 4 findings on the record.
Data: ClinicalTrials.gov API v2 (U.S. National Library of Medicine) ↗, via Coinjure